JP2009534404A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534404A5
JP2009534404A5 JP2009506740A JP2009506740A JP2009534404A5 JP 2009534404 A5 JP2009534404 A5 JP 2009534404A5 JP 2009506740 A JP2009506740 A JP 2009506740A JP 2009506740 A JP2009506740 A JP 2009506740A JP 2009534404 A5 JP2009534404 A5 JP 2009534404A5
Authority
JP
Japan
Prior art keywords
alkyl
och
conhch
pyridyl
propenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009506740A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009534404A (ja
JP5480619B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/066864 external-priority patent/WO2007124318A1/en
Publication of JP2009534404A publication Critical patent/JP2009534404A/ja
Publication of JP2009534404A5 publication Critical patent/JP2009534404A5/ja
Application granted granted Critical
Publication of JP5480619B2 publication Critical patent/JP5480619B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009506740A 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤 Expired - Fee Related JP5480619B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US79369406P 2006-04-20 2006-04-20
US60/793,694 2006-04-20
US87117106P 2006-12-21 2006-12-21
US60/871,171 2006-12-21
PCT/US2007/066864 WO2007124318A1 (en) 2006-04-20 2007-04-18 Inhibitors of c-fms kinase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013228539A Division JP5932754B2 (ja) 2006-04-20 2013-11-01 c−fmsキナーゼの阻害剤

Publications (3)

Publication Number Publication Date
JP2009534404A JP2009534404A (ja) 2009-09-24
JP2009534404A5 true JP2009534404A5 (OSRAM) 2010-05-13
JP5480619B2 JP5480619B2 (ja) 2014-04-23

Family

ID=38457966

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009506740A Expired - Fee Related JP5480619B2 (ja) 2006-04-20 2007-04-18 c−fmsキナーゼの阻害剤
JP2013228539A Expired - Fee Related JP5932754B2 (ja) 2006-04-20 2013-11-01 c−fmsキナーゼの阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013228539A Expired - Fee Related JP5932754B2 (ja) 2006-04-20 2013-11-01 c−fmsキナーゼの阻害剤

Country Status (14)

Country Link
US (3) US8674100B2 (OSRAM)
EP (2) EP2687516A1 (OSRAM)
JP (2) JP5480619B2 (OSRAM)
KR (1) KR101462393B1 (OSRAM)
AR (1) AR060609A1 (OSRAM)
AU (1) AU2007240439B2 (OSRAM)
CA (1) CA2649919C (OSRAM)
ES (1) ES2581600T3 (OSRAM)
MX (1) MX2008013532A (OSRAM)
NZ (1) NZ572201A (OSRAM)
PE (1) PE20080076A1 (OSRAM)
TW (1) TW200808736A (OSRAM)
UY (1) UY30298A1 (OSRAM)
WO (1) WO2007124318A1 (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE032540T2 (en) 2004-06-24 2017-09-28 Vertex Pharma Modulators of ATP-binding cassette transporters
US20060281788A1 (en) * 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
CA2635581C (en) 2005-12-28 2017-02-28 Vertex Pharmaceuticals Incorporated Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
AU2007240439B2 (en) * 2006-04-20 2012-10-11 Janssen Pharmaceutica N.V. Inhibitors of c-fms kinase
US7414050B2 (en) 2006-04-20 2008-08-19 Janssen Pharmaceutica, N.V. Inhibitors of c-fms kinase
EP2016070B1 (en) 2006-04-20 2016-01-13 Janssen Pharmaceutica N.V. Inhibitors of c-fms kinase
US8697716B2 (en) 2006-04-20 2014-04-15 Janssen Pharmaceutica Nv Method of inhibiting C-KIT kinase
JO3240B1 (ar) * 2007-10-17 2018-03-08 Janssen Pharmaceutica Nv c-fms مثبطات كيناز
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
EP2821400B1 (en) 2009-03-20 2017-09-27 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
CN101624376B (zh) * 2009-08-19 2011-09-14 沈阳中海药业有限公司 取代酰肼类化合物及其应用
EP2467373B1 (en) * 2009-08-20 2013-10-02 Cipla Limited A process for the synthesis of naratriptan
EP2627650A2 (en) * 2010-05-26 2013-08-21 Merck Sharp & Dohme Corp. N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
RU2692779C2 (ru) 2012-02-27 2019-06-27 Вертекс Фармасьютикалз Инкорпорейтед Фармацевтическая композиция и ее введения
US9303046B2 (en) 2012-08-07 2016-04-05 Janssen Pharmaceutica Nv Process for the preparation of heterocyclic ester derivatives
JOP20180012A1 (ar) 2012-08-07 2019-01-30 Janssen Pharmaceutica Nv عملية السلفنة باستخدام نونافلوروبوتانيسولفونيل فلوريد
EP2895478B1 (en) * 2012-09-17 2016-10-19 F. Hoffmann-La Roche AG Triazole carboxamide derivatives
JP6318467B2 (ja) * 2013-04-18 2018-05-09 Jsr株式会社 液晶配向剤、液晶配向膜、液晶表示素子、位相差フィルム、位相差フィルムの製造方法及び重合体
US10959987B2 (en) 2019-04-15 2021-03-30 King Abdulaziz University Imidazole-based compounds as hepatitis C virus inhibitors
WO2021144360A1 (en) 2020-01-17 2021-07-22 F. Hoffmann-La Roche Ag Small molecule csf-1r inhibitors in therapeutic and cosmetic uses

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69211015T2 (de) * 1991-11-27 1997-01-09 Du Pont Herbizide acylierte amino-(phenyl-oder-pyridinyl-oder thienyl-)phenyl derivate
EP0785937A1 (en) 1994-10-14 1997-07-30 Smithkline Beecham Plc 2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
WO1997020822A1 (en) 1995-12-01 1997-06-12 Novartis Ag Quinazolin-2,4-diazirines as npy receptor antagonist
US6100254A (en) 1997-10-10 2000-08-08 Board Of Regents, The University Of Texas System Inhibitors of protein tyrosine kinases
GB9824579D0 (en) 1998-11-10 1999-01-06 Novartis Ag Organic compounds
EP1140938B1 (en) 1999-01-11 2003-08-27 Princeton University High affinity inhibitors for target validation and uses thereof
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
JP2003519143A (ja) 1999-12-28 2003-06-17 ファーマコピーア,インコーポレーティッド ピリミジン及びトリアジン系キナーゼ阻害剤
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
US7790724B2 (en) * 2003-04-25 2010-09-07 Janssen Pharmaceutica N.V. c-fms kinase inhibitors
US20050113566A1 (en) * 2003-04-25 2005-05-26 Player Mark R. Inhibitors of C-FMS kinase
US7427683B2 (en) * 2003-04-25 2008-09-23 Ortho-Mcneil Pharmaceutical, Inc. c-fms kinase inhibitors
CA2536964A1 (en) * 2003-04-25 2004-11-11 Ortho-Mcneil Pharmaceutical, Inc. C-fms kinase inhibitors
NZ555289A (en) * 2004-10-22 2010-10-29 Janssen Pharmaceutica Nv Inhibitors of c-fms kinase
US7645755B2 (en) * 2004-10-22 2010-01-12 Janssen Pharmaceutical N.V. Inhibitors of c-fms kinase
JP5008569B2 (ja) * 2004-10-22 2012-08-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ C−fmsキナーゼのインヒビターとしての芳香族アミド
EP2004659A1 (en) * 2006-04-12 2008-12-24 Wyeth Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
AU2007240439B2 (en) * 2006-04-20 2012-10-11 Janssen Pharmaceutica N.V. Inhibitors of c-fms kinase
EP2016070B1 (en) * 2006-04-20 2016-01-13 Janssen Pharmaceutica N.V. Inhibitors of c-fms kinase
US7414050B2 (en) * 2006-04-20 2008-08-19 Janssen Pharmaceutica, N.V. Inhibitors of c-fms kinase
FR2966596B1 (fr) * 2010-10-26 2012-12-07 Commissariat Energie Atomique Dispositif de detection d'un rayonnement electromagnetique.

Similar Documents

Publication Publication Date Title
JP2009534404A5 (OSRAM)
JP2009534407A5 (OSRAM)
JP2008510828A5 (OSRAM)
JP2002524463A5 (OSRAM)
JP2011507878A5 (OSRAM)
JP2012524111A5 (OSRAM)
JP2012510523A5 (OSRAM)
JP2009534406A5 (OSRAM)
JP2013532726A5 (OSRAM)
JP2007501859A5 (OSRAM)
JP2007518738A5 (OSRAM)
JP2008505120A5 (OSRAM)
JP2009504772A5 (OSRAM)
JP2012530713A5 (OSRAM)
JP2019518766A5 (OSRAM)
CA2796967A1 (en) Heterocyclic derivatives as alk inhibitors
JP2009539828A5 (OSRAM)
JP2009545611A5 (OSRAM)
JP2007269797A5 (OSRAM)
RU2003133448A (ru) 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс- хемокинового рецептора
JP2006515858A5 (OSRAM)
JP2010539110A5 (OSRAM)
JP2005511608A5 (OSRAM)
JP2013510825A5 (OSRAM)
JP2010514681A5 (OSRAM)